4//SEC Filing
Randolph Sophia 4
Accession 0001209191-22-062178
CIK 0001810182other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:08 PM ET
Size
14.7 KB
Accession
0001209191-22-062178
Insider Transaction Report
Form 4
Randolph Sophia
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-16$4.81/sh+25,339$121,881→ 271,870 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-16−25,339→ 25,340 totalExercise: $4.81Exp: 2030-04-27→ Common Stock (25,339 underlying) - Exercise/Conversion
Common Stock
2022-12-16$1.91/sh+8,404$16,052→ 233,800 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-16−12,731→ 95,175 totalExercise: $4.08Exp: 2030-03-09→ Common Stock (12,731 underlying) - Exercise/Conversion
Common Stock
2022-12-16$4.08/sh+12,731$51,942→ 246,531 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-16−8,404→ 4,027 totalExercise: $1.91Exp: 2029-09-12→ Common Stock (8,404 underlying)
Footnotes (3)
- [F1]The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
- [F2]The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
- [F3]Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.
Documents
Issuer
ALX ONCOLOGY HOLDINGS INC
CIK 0001810182
Entity typeother
Related Parties
1- filerCIK 0001817127
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:08 PM ET
- Size
- 14.7 KB